Accurate, safe prescribing information for children is often unavailable to doctors in Canada because pharmaceutical companies will not disclose information to Health Canada, states an editorial in CMAJ (Canadian Medical ...
Jun 13, 2011
0
0
Cancer arises when cells accumulate enough damage to change their normal behavior. The likelihood of accruing damage increases with age because the safeguards in your genetic code that ensure cells function for the greater ...
Oct 10, 2023
0
1
(HealthDay)—The incidence of pediatric melanoma has increased by about 2 percent per year, and this incidence trend is influenced by gender, age, and stage at diagnosis, primary site, and ultraviolet (UV)-B exposure, according ...
Apr 16, 2013
0
0
Youth-onset type 2 diabetes is increasing globally as a result of pediatric obesity. A new study in Diabetic Medicine shows that young adults with type 2 diabetes have substantially worse blood sugar control and loss to follow-up ...
Mar 12, 2018
0
1
In a first-of-its-kind study, researchers at University Hospitals Rainbow Babies & Children's Hospital (UH Rainbow) found that lap infants may be at greater risk for death on a commercial airline flight. The study analyzed ...
Aug 1, 2014
0
0
Imaging tests of obese children—some as young as 8 years old—showed signs of significant heart disease and heart muscle abnormalities, according to research presented at the American Heart Association's Scientific Sessions ...
Nov 10, 2015
0
12
A comprehensive genomic profiling test using next-generation sequencing has identified genomic alterations in more than half of pediatric cancer samples tested that would give clinicians potential targets on which to base ...
Nov 5, 2013
0
0
(HealthDay)—The anti-cancer drug Gleevec (imatinib) has received new U.S. Food and Drug Administration approval to treat the most common type of pediatric cancer, affecting some 2,900 children each year, the agency said ...
Jan 25, 2013
0
0
Children with inflammatory bowel disease (IBD) who are doing well on specific biological medications should not be switched to recently approved "biosimilar" products, concludes an expert consensus statement of the European ...
Jul 13, 2015
0
9
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational ...
Sep 2, 2020
0
22
